Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
A blocking peptide from ATG7.
Synthetic
The ATG7 Blocking Peptide has been validated for the following applications: Antibody Competition.
| Marque | Novus Biologicals |
|---|---|
| Réf. B-LABO | BL-RE-043829 |
| Réf. fabricant | 18065817 |
| Gene ID (Entrez) | 10533 |
| Espèces | Human |
| Pureté | >95% |
| Numéro d’adhésion | O95352, O95352, O95352, O95352 |
| Contenu et stockage | Store at -20 C short term. Aliquot and store (at -80 C long term. Avoid freeze-thaw cycles.) |
| Formule | 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 |
| À utiliser avec (application) | This product should be used at 1.0μg per 1.0μL of antiserum in per assay. |
| Alias de gène | APG7 autophagy 7-like (S. cerevisiae), APG7L, APG7-LIKE, ATG12-activating enzyme E1 ATG7, ATG7 autophagy related 7 homolog (S. cerevisiae), Autophagy-related protein 7, DKFZp434N0735, GSA7, hAGP7, ubiquitin activating enzyme E1-like protein, Ubiquitin-activating enzyme E1-like protein, ubiquitin-like modifier-activating enzyme ATG7 |
| Symbole de gène(s) | ATG7 |
| Type de produit | ATG7 Peptide |
| Quantité | 0.05 mg |
| État réglementaire | RUO - research use only |
| Source | Synthetic |
| Consigne | Sequence: Glu -Val - His - His - Gln - Lys-Leu - Val - Phe - Phe-OH (aa 11-20) |
